These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15951694

  • 1. Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats.
    Fukuda S, Iida H, Ikeda M, Yan X, Xie Y.
    Health Phys; 2005 Jul; 89(1):81-8. PubMed ID: 15951694
    [Abstract] [Full Text] [Related]

  • 2. Effects of pH on du intake and removal by CBMIDA and EHBP.
    Fukuda S, Ikeda M, Nakamura M, Yan X, Xie Y.
    Health Phys; 2007 Jan; 92(1):10-4. PubMed ID: 17164594
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium.
    Fukuda S, Ikeda M, Nakamura M, Yan X, Xie Y.
    Radiat Prot Dosimetry; 2009 Jan; 133(1):12-9. PubMed ID: 19168864
    [Abstract] [Full Text] [Related]

  • 4. Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
    Fukuda S, Ikeda M, Nakamura M, Yan X, Xie Y.
    Health Phys; 2009 Apr; 96(4):483-92. PubMed ID: 19276709
    [Abstract] [Full Text] [Related]

  • 5. Orally administered ethane-1-hydroxy-1,1-biphosphonate reduces the lethal effect of oral uranium poisoning.
    Martínez AB, Cabrini RL, Ubios AM.
    Health Phys; 2000 Jun; 78(6):668-71. PubMed ID: 10832926
    [Abstract] [Full Text] [Related]

  • 6. Effect of biphosphonates on abnormal mandibular growth of rats intoxicated with uranium.
    Ubios AM, Braun EM, Cabrini RL.
    Health Phys; 1998 Dec; 75(6):610-3. PubMed ID: 9827507
    [Abstract] [Full Text] [Related]

  • 7. Inositol hexaphosphate: a potential chelating agent for uranium.
    Cebrian D, Tapia A, Real A, Morcillo MA.
    Radiat Prot Dosimetry; 2007 Dec; 127(1-4):477-9. PubMed ID: 17627956
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOX.
    Paquet F, Chazel V, Houpert P, Guilmette R, Muggenburg B.
    Radiat Prot Dosimetry; 2003 Dec; 105(1-4):521-5. PubMed ID: 14535232
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
    Ramounet-Le Gall B, Grillon G, Rateau G, Burgada R, Bailly T, Fritsch P.
    Radiat Prot Dosimetry; 2003 Dec; 105(1-4):535-8. PubMed ID: 14527023
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW, Kullgren B, Xu J, Raymond KN.
    Health Phys; 1997 Jun; 72(6):865-79. PubMed ID: 9169929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.